GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Applied BioCode Corp (TPE:6598) » Definitions » 1-Year ROIIC %

Applied BioCode (TPE:6598) 1-Year ROIIC % : 192.41% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Applied BioCode 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Applied BioCode's 1-Year ROIIC % for the quarter that ended in Dec. 2024 was 192.41%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Applied BioCode's 1-Year ROIIC % or its related term are showing as below:

TPE:6598's 1-Year ROIIC % is ranked better than
87.77% of 834 companies
in the Medical Devices & Instruments industry
Industry Median: 1.72 vs TPE:6598: 192.41

Applied BioCode 1-Year ROIIC % Historical Data

The historical data trend for Applied BioCode's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied BioCode 1-Year ROIIC % Chart

Applied BioCode Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 234.51 -241.09 -951.61 34.81 192.41

Applied BioCode Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.81 -104.03 -99.53 12.47 192.41

Competitive Comparison of Applied BioCode's 1-Year ROIIC %

For the Medical Devices subindustry, Applied BioCode's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied BioCode's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Applied BioCode's 1-Year ROIIC % falls into.


;
;

Applied BioCode 1-Year ROIIC % Calculation

Applied BioCode's 1-Year ROIIC % for the quarter that ended in Dec. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -277.6967669 (Dec. 2024) - -187.2704998 (Dec. 2023) )/( 299.446 (Dec. 2024) - 346.442 (Dec. 2023) )
=-90.4262671/-46.996
=192.41%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Applied BioCode  (TPE:6598) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Applied BioCode 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Applied BioCode's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied BioCode Business Description

Traded in Other Exchanges
N/A
Address
12130 Mora Dr., Unit 2,, Santa Fe Springs, CA, USA, 90670
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.

Applied BioCode Headlines

No Headlines